Director Valley Medical Primary Care and Valley Medical Research Dayton, Ohio
Disclosure information not submitted.
Disclosure(s):
Naushira Pandya, MD, CMD, FACP: No relevant financial relationships.
Meenakshi Patel, MD, FACP, MMM, CMD: No relevant financial relationships.
Elizabeth Hames, DO, CMD: No relevant financial relationships.
In this session, three experienced clinicians will provide a roadmap for all practitioners in the PALTC setting to manage osteoporosis utilizing updated guidelines, systematically evaluate hypercalcemia and hyperparathyroidism, decipher imaging and laboratory findings of adrenal hyper and hypofunction, and look for potential endocrine disorders in patients with refractory gastrointestinal symptoms.
Learning Objectives:
At the completion of this session, learners will be able to:
Employ treatment recommendations from the updated 2021 osteoporosis guidelines
Differentiate between primary and secondary hypothyroidism, and determine the management of hyperparathyroidism
Identify clinical or laboratory findings indicating adrenal dysfunction, and initiate a preliminary evaluation
Recognize that patients with refractory gastrointestinal symptoms, may have an underlying endocrine disorder
.png)
.png)
